O ne vital goal of cancer research is a test that profiles individual tumors at the molecular level in order to guide treatment. Some single-marker predictive tests are now standard, as are two well-validated genomic prognostic tests for breast cancer. But for most tumors, such personalized tests are still viewed as futuristic. At a recent cancer molecular diagnostics conference, many genomic t...

Toxoplasma gondii infects all species of warm-blooded animals, including humans, and domestic cats and other felidae are its definitive hosts. The aim of the present survey was to compare serological and molecular tests in accurate diagnosis of T. gondii infection among stray cats in Ahvaz, Iran. A total of 100 cats were examined for the detection of serum antibodies against T. gondii (chronic ...

OBJECTIVE To describe the molecular markers thus far evaluated for use in the care of patients with clinically relevant thyroid nodules. METHODS We review the currently available molecular tests that have been applied to patients with thyroid nodules. RESULTS In the United States, approximately 450 000 diagnostic fine-needle aspirates will be performed on patients with thyroid nodules this ...

Molecular profiling for malignant tumors catalogues specific biomarker information and generates potential treatment options. The personalized tumor molecular profiling services or tests are similar in that they all take an individual's tumor tissue and, from it, produce a molecular profile of the tumor and a list of potential therapies. However, their individual testing methods vary from match...

I. Description Molecular profiling for malignant tumors catalogues specific biomarker information and generates potential treatment options. The personalized tumor molecular profiling services or tests are similar in that they all take an individual's tumor tissue and, from it, produce a molecular profile of the tumor and a list of potential therapies. However, their individual testing methods ...